<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="158254">
  <!-- This xml conforms to an XML Schema at:
    http://clinicaltrials.gov/ct2/html/images/info/public.xsd
 and an XML DTD at:
    http://clinicaltrials.gov/ct2/html/images/info/public.dtd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on June 04, 2014</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>http://clinicaltrials.gov/show/NCT02134093</url>
  </required_header>
  <id_info>
    <org_study_id>Tangdu sedation</org_study_id>
    <nct_id>NCT02134093</nct_id>
  </id_info>
  <brief_title>Effects of Dexmedetomidine on Postoperative Cognitive Dysfunction During One-lung Ventilation in Elder Patients</brief_title>
  <official_title>Effects of Dexmedetomidine on Postoperative Cognitive Dysfunction During One-lung Ventilation in Elder Patients -a Single-center, Randomized ,Double-blinded and Controlled Trial</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Tang-Du Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Tang-Du Hospital</source>
  <oversight_info>
    <authority>China: Food and Drug Administration</authority>
  </oversight_info>
  <brief_summary>
    <textblock>
      This study is to explore the effects of dexmedetomidine  on postoperative cognitive
      dysfunction during one-lung ventilation in elder patients.
    </textblock>
  </brief_summary>
  <overall_status>Not yet recruiting</overall_status>
  <start_date>May 2014</start_date>
  <completion_date type="Anticipated">December 2015</completion_date>
  <primary_completion_date type="Anticipated">May 2015</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <study_design>Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Investigator), Primary Purpose: Prevention</study_design>
  <primary_outcome>
    <measure>The change  in learning</measure>
    <time_frame>one day before operation , first day and seventh day  after operation</time_frame>
    <safety_issue>No</safety_issue>
    <description>The change  in learning  will be evaluated by Rey Auditory Verbal Learning Test</description>
  </primary_outcome>
  <primary_outcome>
    <measure>The change  in memory</measure>
    <time_frame>one day before operation, first day and seventh day after operation</time_frame>
    <safety_issue>No</safety_issue>
    <description>The change  in memory will be evaluated by Rey Auditory Verbal Learning Test,Controlled Oral Word Association Test ,Semantic Fluency test ,</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Cognitive function</measure>
    <time_frame>one day before operation, first day and seventh day after operation</time_frame>
    <safety_issue>No</safety_issue>
    <description>Cognitive function will be  evaluated by Mini-mentalStateExamination,Digit-Symbol Substitution Test ,Trail Making Test , Grooved Pegboard Dominant Hand</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Postoperative anxiety</measure>
    <time_frame>one day before operation, first day and seventh day after operation</time_frame>
    <safety_issue>No</safety_issue>
    <description>Self-evaluation of Depression Symptoms form,Self-Rating Anxiety Scale,Visual analog scales</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Variation degree of Heart rate</measure>
    <time_frame>Prior to surgery，prior to lung ventilation,10 minutes,30 minutes and 60 minutes afer lung ventilation,weaning,and postoperation</time_frame>
    <safety_issue>No</safety_issue>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Airway pressure</measure>
    <time_frame>Prior to surgery，prior to lung ventilation,10 minutes,30 minutes and 60 minutes afer lung ventilation,weaning,and postoperation</time_frame>
    <safety_issue>No</safety_issue>
    <description>Variation degree of airway pressure</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Variation degree of blood gas analysis</measure>
    <time_frame>Prior to surgery，prior to lung ventilation,10 minutes,30 minutes and 60 minutes afer lung ventilation,weaning,and postoperation</time_frame>
    <safety_issue>No</safety_issue>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Bleeding volume</measure>
    <time_frame>At the beginning of surgery,at the end of surgery,up to 24 hours</time_frame>
    <safety_issue>No</safety_issue>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Total volume of  fluid</measure>
    <time_frame>At the beginning of surgery,at the end of surgery,up to 24 hours</time_frame>
    <safety_issue>No</safety_issue>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Duration of one lung ventilation</measure>
    <time_frame>At the beginning of one lung ventilation,at the end of one lung ventilation,an expected average of 3 hours</time_frame>
    <safety_issue>No</safety_issue>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Duration of  two-lung ventilations</measure>
    <time_frame>At the beginning of two-lung ventilations,at the end of two-lung ventilations, an expected average of  3 hours</time_frame>
    <safety_issue>No</safety_issue>
  </secondary_outcome>
  <secondary_outcome>
    <measure>The total dose of  anaesthetic drugs</measure>
    <time_frame>At the beginning of surgery,at the end of surgery,up to 24 hours</time_frame>
    <safety_issue>No</safety_issue>
  </secondary_outcome>
  <secondary_outcome>
    <measure>The total dose of analgesic drugs</measure>
    <time_frame>During perioperative period,up to 7 days</time_frame>
    <safety_issue>No</safety_issue>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Variation degree of  blood pressure</measure>
    <time_frame>Prior to surgery，prior to lung ventilation,10 minutes,30 minutes and 60 minutes afer lung ventilation,weaning,and postoperation</time_frame>
    <safety_issue>No</safety_issue>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Oxygen saturation</measure>
    <time_frame>Prior to surgery，prior to lung ventilation,10 minutes,30 minutes and 60 minutes afer lung ventilation,weaning,and postoperation</time_frame>
    <safety_issue>No</safety_issue>
  </secondary_outcome>
  <secondary_outcome>
    <measure>End-tidal carbon dioxide</measure>
    <time_frame>Prior to surgery，prior to lung ventilation,10 minutes,30 minutes and 60 minutes afer lung ventilation,weaning,and postoperation</time_frame>
    <safety_issue>No</safety_issue>
  </secondary_outcome>
  <number_of_arms>3</number_of_arms>
  <enrollment type="Anticipated">540</enrollment>
  <condition>Postoperative Confusion</condition>
  <arm_group>
    <arm_group_label>Normal saline</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>Continuous pump infusion of normal saline with  identical  volume, compared with  the low dose and high dose group,until 30 minutes before the end of surgery</description>
  </arm_group>
  <arm_group>
    <arm_group_label>High dose group, dexmedetomidine</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Continuous pump infusion  dexmedetomidine at 0.7 μg/kg/h until 30 minutes before the end of surgery</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Low dose  group, dexmedetomidine</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Continuous pump infusion dexmedetomidine at 0.4 μg/kg/h  until 30 minutes before the end of surgery</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Induction of anesthesia,midazolam ,fentanyl,etomidate and rocuronium</intervention_name>
    <description>Anesthesia induction:midazolam (0.03~0.05 mg/kg), fentanyl( 5~8 μg/kg), etomidate ( 0.15~0.2 mg/kg) and rocuronium(0.6mg/kg)</description>
    <arm_group_label>Normal saline</arm_group_label>
    <arm_group_label>High dose group, dexmedetomidine</arm_group_label>
    <arm_group_label>Low dose  group, dexmedetomidine</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Dexmedetomidine</intervention_name>
    <description>Continuous pump infusion dexmedetomidine at 1μg/kg  over 10 minute，then followed by a continuous pump infusion at 0.4 μg/kg/h（low dose group）or  0.7μg/kg/h until 30 minutes before the end of surgery.</description>
    <arm_group_label>High dose group, dexmedetomidine</arm_group_label>
    <arm_group_label>Low dose  group, dexmedetomidine</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Normal saline</intervention_name>
    <description>Continuous pump infusion normal saline with identical volume of dexmedetomidine.</description>
    <arm_group_label>Normal saline</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Maintenance of anesthesia , propofol, remifentanil,vecuronium</intervention_name>
    <description>Continuous infusion of propofol （4~6 mg/kg/h）, remifentanil （0.1~0.3 μg/kg/min）is required to maintain the Bispectral Index within 40~60,Mean Arterial Blood Pressure more than 20% of baseline level , Oxygen Saturation more than 90% , airway pressure less than 40 cm H2O, intermittent injection vecuronium （0.05~0.1mg/kg） as needed to maintain muscle relaxation.</description>
    <arm_group_label>Normal saline</arm_group_label>
    <arm_group_label>High dose group, dexmedetomidine</arm_group_label>
    <arm_group_label>Low dose  group, dexmedetomidine</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Written informed consent.

          -  Ongoing one-lung ventilation surgery.

          -  American Society of Anesthesiologists class I to III.

          -  Aged between 55 and 75 years old.

          -  Body Mass Index between 18 and 25 kg/m2.

        Exclusion Criteria:

          -  Systolic blood pressure more than 180 mmHg or lower than 90 mmHg,diastolic blood
             pressure  more than 110 mmHg or lower than 60 mmHg.

          -  Serious heart,liver,kidney, pulmonary, and endocrine disease or serious infection.

          -  Suspected or confirmed  difficult airway.

          -  History of abnormal anesthesia.

          -  Suspected of malignant hyperthermia.

          -  Use of sedative and antidepressant drug  or  serious alcoholism

          -  Mini-mental State Examination less than 17.

          -  Highest academic degree below grade 6 in primary schools

          -  Patients inability to exchange with serious visual and hearing impairment  or mental
             disability.

          -  History  of  shock.

          -  Carotid artery stenosis and  central nervous system disease such as stroke, epilepsy.

          -  Allergic to investigational products or with other contraindication.

          -  Participated in other study within 30 days .
      </textblock>
    </criteria>
    <gender>Both</gender>
    <minimum_age>55 Years</minimum_age>
    <maximum_age>75 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <verification_date>May 2014</verification_date>
  <lastchanged_date>May 6, 2014</lastchanged_date>
  <firstreceived_date>April 29, 2014</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Tang-Du Hospital</investigator_affiliation>
    <investigator_full_name>YangLu</investigator_full_name>
    <investigator_title>physician</investigator_title>
  </responsible_party>
  <is_fda_regulated>No</is_fda_regulated>
  <has_expanded_access>No</has_expanded_access>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Confusion</mesh_term>
    <mesh_term>Cognition Disorders</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Anesthetics</mesh_term>
    <mesh_term>Midazolam</mesh_term>
    <mesh_term>Etomidate</mesh_term>
    <mesh_term>Fentanyl</mesh_term>
    <mesh_term>Propofol</mesh_term>
    <mesh_term>Remifentanil</mesh_term>
    <mesh_term>Dexmedetomidine</mesh_term>
    <mesh_term>Vecuronium Bromide</mesh_term>
    <mesh_term>Rocuronium</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
